Want to see ACH full AI Analyst Report?
ACH Stock Chart & Stats
$2.57
--
Market closed
$2.57
--
Day’s Range― - ―
52-Week Range$1.84 - $8.40
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.12M
Market Cap
$278.00M
Enterprise Value$2.01K
Total Cash (Recent Filing)$336.88M
Total Debt (Recent Filing)$2.17B
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Jul 31, 2026EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-14.05
Shares Outstanding76,583,700
10 Day Avg. Volume949,424
30 Day Avg. Volume1,122,390
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.47
Price to Sales (P/S)0.08
P/FCF Ratio-0.71
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$5.17Price Target Upside101.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.7
Revenue Forecast (FY)$2.59B
Bulls Say, Bears Say
Bulls Say
Debt Extension & RestructuringExtending maturities and refinancing into new first‑ and second‑lien notes materially reduces near‑term rollover risk and doubles weighted‑average debt life to ~5.5 years. This gives management time to execute cost savings and de‑leveraging without immediate liquidity stress, improving structural solvency over months.
Solid Liquidity CushionA cash balance plus committed revolver provides a durable operational buffer while the company implements margin and collection improvements and completes refinancing. That liquidity reduces short‑term funding risk and supports working capital needs during the multi‑quarter recovery.
Margin TransformationA structural shift to higher gross margins from a focused home‑based care model suggests improved unit economics and pricing power. If sustained, this transforms cash generation potential and makes adjusted EBITDA more resilient to volume shocks, supporting longer‑term profitability.
Bears Say
Sharp Revenue DeclineA large, persistent revenue contraction reduces scale benefits and makes fixed costs proportionally heavier. Even with margin initiatives, a materially smaller top line constrains cash flow recovery, raises unit cost risk, and lengthens the timeline to sustainable profitability and normalized leverage.
Negative Operating & Free Cash FlowConsistent negative operating and free cash flow forces reliance on financing to fund operations and deleveraging. Weak internal cash generation constrains capital allocation flexibility, makes the company sensitive to higher interest costs, and elevates refinancing and covenant risk over months.
Higher Interest Burden & Elevated DebtA structurally higher cash interest burden combined with elevated debt and negative equity reduces free cash flow available for debt paydown. This amplifies sensitivity to operational slippage, limits strategic flexibility, and prolongs the period before meaningful deleveraging can restore balance‑sheet strength.
Accendra Health News
ACH FAQ
What was Accendra Health’s price range in the past 12 months?
Accendra Health lowest stock price was $1.84 and its highest was $8.40 in the past 12 months.
What is Accendra Health’s market cap?
Accendra Health’s market cap is $278.00M.
When is Accendra Health’s upcoming earnings report date?
Accendra Health’s upcoming earnings report date is Jul 31, 2026 which is in 14 days.
How were Accendra Health’s earnings last quarter?
Accendra Health released its earnings results on May 11, 2026. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.098 by $0.058.
Is Accendra Health overvalued?
According to Wall Street analysts Accendra Health’s price is currently Undervalued.
Does Accendra Health pay dividends?
Accendra Health pays a N/A dividend of $0.002 which represents an annual dividend yield of N/A. See more information on Accendra Health dividends here
What is Accendra Health’s EPS estimate?
Accendra Health’s EPS estimate is -0.08.
How many shares outstanding does Accendra Health have?
Accendra Health has 76,583,700 shares outstanding.
What happened to Accendra Health’s price movement after its last earnings report?
Accendra Health reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.098. Following the earnings report the stock price went up 8.659%.
Which hedge fund is a major shareholder of Accendra Health?
Currently, no hedge funds are holding shares in ACH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Accendra Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.17 (101.04% Upside)
$5.17 (101.04% Upside)
Blogger Sentiment
Bullish
ACH Sentiment 100%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 635.6K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.19%
12-Months-Change
Fundamentals
Return on Equity
264.54%
Trailing 12-Months
Asset Growth
-50.25%
Trailing 12-Months
Company Description
Accendra Health
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
ACH Stock 12 Month Forecast
Average Price Target
$5.17
▲(101.04% Upside)
Ownership Overview
20.56% Insiders
19.36% Mutual Funds
0.05% Other Institutional Investors
46.24% Public Companies and
Individual Investors